Insta
Dr Reddy's Gets DCGI Approval For Phase 3 Bridging Trials Of Single-Dose Sputnik Light Covid-19 Vaccine
Swarajya Staff
Sep 15, 2021, 12:45 PM | Updated 12:45 PM IST
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
The Drug Controller General of India (DCGI) has given approval to Hyderabad-based pharma major Dr Reddy's to conduct phase-3 bridging trials of Russian Covid-19 vaccine Sputnik Light on the Indian population.
The drug regulator's nod comes after Dr Redyy's submitted safety and immunogenicity data along with the information on longevity of the antibodies which gives a measure of persistence antibodies in the participants to the Subject Expert Committee (SEC) of DCGI.
“After detailed deliberation, the committee recommended for grant of permission for conduct of Phase III immune bridging clinical trial in Indian population,” said the minutes of the meeting, reports Economic Times.
The Sputnik Light is made from the first part of the of the two-dose Sputnik V Covid-19 vaccine, which comprises two components - recombinant adenovirus 26 or Ad26 and adenovirus 5 or Ad5.
The Sputnik Light vaccine is made from Ad26, the first part of the Sputnik V vaccine.
The single-dose vaccine, developed by the Gamaleya National Research Centre of Epidemiology and Microbiology and the Russian Direct Investment Fund, was introduced in Russia in May.
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.